You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 18, 2024

ATARAX Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Atarax, and what generic alternatives are available?

Atarax is a drug marketed by Roerig and Pfizer and is included in two NDAs.

The generic ingredient in ATARAX is hydroxyzine hydrochloride. There are nineteen drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the hydroxyzine hydrochloride profile page.

Drug patent expirations by year for ATARAX
Drug Sales Revenue Trends for ATARAX

See drug sales revenues for ATARAX

Recent Clinical Trials for ATARAX

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Sultan Qaboos UniversityPhase 4
Bnai Zion Medical CenterN/A
University Hospital, Clermont-FerrandPhase 4

See all ATARAX clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for ATARAX

US Patents and Regulatory Information for ATARAX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roerig ATARAX hydroxyzine hydrochloride SYRUP;ORAL 010485-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Pfizer ATARAX hydroxyzine hydrochloride TABLET;ORAL 010392-006 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Pfizer ATARAX hydroxyzine hydrochloride TABLET;ORAL 010392-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Pfizer ATARAX hydroxyzine hydrochloride TABLET;ORAL 010392-004 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Pfizer ATARAX hydroxyzine hydrochloride TABLET;ORAL 010392-005 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.